📰 Alrn News
Page 2 - Alrn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alrn. Real-time updates on events, politics, business and more.
March 26, 2023
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) is set to issue its quarterly earnings data on Monday, March 27th. Aileron Therapeutics Trading Up 2.9 % Shares of ALRN stock opened at $1.39 on Friday. Aileron Therapeutics has a 12-month low of $1.25 and a 12-month high of $15.00. The business’s 50 day moving average is $2.13 […]
June 13, 2022
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 197,300 shares, a decline of 39.6% from the May 15th total of 326,900 shares. Based on an average daily volume of 350,100 shares, the days-to-cover ratio is […]
June 10, 2022
Brokerages predict that Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) will report earnings per share (EPS) of ($0.09) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Aileron Therapeutics’ earnings. Aileron Therapeutics reported earnings of ($0.06) per share in the same quarter last year, which indicates a negative year-over-year […]
May 31, 2022
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. […]
May 20, 2022
Brokerages forecast that Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) will report earnings of ($0.09) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Aileron Therapeutics’ earnings. Aileron Therapeutics posted earnings per share of ($0.06) in the same quarter last year, which suggests a negative year over […]
May 17, 2022
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 153,600 shares, a drop of 17.0% from the April 15th total of 185,100 shares. Based on an average daily trading volume, of 360,700 shares, the days-to-cover ratio […]
May 13, 2022
Zacks Investment Research downgraded shares of Aileron Therapeutics (NASDAQ:ALRN – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in […]
April 2, 2022
HC Wainwright reiterated their buy rating on shares of Aileron Therapeutics (NASDAQ:ALRN – Get Rating) in a research report released on Tuesday morning, Zacks.com reports. Separately, Zacks Investment Research raised Aileron Therapeutics from a sell rating to a hold rating in a research report on Tuesday, January 4th. Shares of NASDAQ:ALRN opened at $0.55 on […]
March 29, 2022
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) released its quarterly earnings data on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.08), MarketWatch Earnings reports. Shares of ALRN stock opened at $0.53 on Tuesday. The stock’s fifty day moving average is $0.43 and its 200-day moving average […]